Latest News

New Clinical Trial for those with Primary Progressive MS – Now recruiting

June 14, 2021 | Advocacy, Treatments, Trials

About 10% of people with MS are diagnosed with Primary Progressive Multiple Sclerosis (PPMS). While more common forms of MS involve a relapse-remit pattern (unpredictable attacks followed by periods of disease inactivity), PPMS is characterised by a slow onset and […]